Psoriasis induced at the injection site of recombinant interferons.
Kowalzick
L
L
Weyer
U
U
D000368:Aged; D002280:Basal Cell Carcinoma / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D007370:Interferon Type I / Q000009:adverse effects*; D008297:Male; D011565:Psoriasis / Q000209:etiology*; D011994:Recombinant Proteins / Q000009:adverse effects; D012878:Skin Neoplasms / Q000628:therapy*
D007370:Interferon Type I; D011994:Recombinant Proteins